(Q37286248)

English

Myeloablative allogeneic bone marrow transplant using T cell depleted allografts followed by post-transplant GM-CSF in high-risk myelodysplastic syndromes

scientific article published on 07 February 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Myeloablative allogeneic bone marrow transplant using T cell depleted allografts followed by post-transplant GM-CSF in high-risk myelodysplastic syndromes (English)

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

author name string

Erica D Warlick

1

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Paul V O'Donnell

2

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Michael Borowitz

3

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Nichon Grupka

4

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Lauren Decloe

5

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Elizabeth Garrett-Mayer

6

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Ivan Borrello

7

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Robert Brodsky

8

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Ephraim Fuchs

9

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Carol Ann Huff

10

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Leo Luznik

11

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

William Matsui

12

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Richard Ambinder

13

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Richard J Jones

14

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

B Douglas Smith

15

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

publication date

7 February 2008

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Leukemia Research

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

32

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

9

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

1439-1447

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719785

6 September 2017

Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719785

6 September 2017

Epidemiological features of myelodysplastic syndromes: results from regional cancer surveys and hospital-based statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719785

6 September 2017

Development of a prognostic model for grading chronic graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719785

6 September 2017

International scoring system for evaluating prognosis in myelodysplastic syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719785

6 September 2017

1994 Consensus Conference on Acute GVHD Grading

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719785

6 September 2017

Requirement for myeloid growth factors in the differentiation of acute promyelocytic leukaemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719785

14 September 2017

High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719785

14 September 2017

Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719785

26 June 2018

Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndrome: a survey by the Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719785

26 June 2018

The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719785

3 September 2018

Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719785

3 September 2018

Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719785

3 September 2018

Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719785

3 September 2018

Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719785

3 September 2018

Ablative allogeneic hematopoietic cell transplantation in adults 60 years of age and older

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719785

3 September 2018

Long-term follow-up of T cell-depleted allogeneic bone marrow transplantation in refractory multiple myeloma: importance of allogeneic T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719785

3 September 2018

Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719785

3 September 2018

Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719785

3 September 2018

The role of growth factors in the activity of pharmacological differentiation agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719785

3 September 2018

Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719785

3 September 2018

Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/18261793

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18261793

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Busulfan disposition: the role of therapeutic monitoring in bone marrow transplantation induction regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/18261793

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Société Française de Greffe de Moelle

1 reference

https://pubmed.ncbi.nlm.nih.gov/18261793

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic bone marrow transplantation for acute leukemia in patients over the age of 40 years. Acute Leukemia Working Party of the European Group for Bone Marrow Transplantation (EBMT)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18261793

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome of allogeneic bone marrow transplantation with lymphocyte-depleted marrow grafts in adult patients with myelodysplastic syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18261793

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18261793

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimating leukemia-free survival after allografting for chronic myeloid leukemia: a new method that takes into account patients who relapse and are restored to complete remission

1 reference

https://pubmed.ncbi.nlm.nih.gov/18261793

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18261793

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/18261793

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of relapsing leukemia after allogeneic blood stem cell transplantation by using dose-reduced conditioning followed by donor blood stem cells and GM-CSF

1 reference

https://pubmed.ncbi.nlm.nih.gov/18261793

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.LEUKRES.2007.12.017

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37286248&oldid=2120381883"